VEGF Receptor 2 (VEGFR2) Peptid
VEGFR2
Reaktivität: Human
Wirt: Synthetic
BP
-
- Target Alle VEGFR2/CD309 (VEGFR2) Produkte
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
- Protein-Typ
- Synthetic
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-VEGFR2 Antibody reactivity.
-
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
- Hintergrund
- FLK1, VEGFR2, Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, FLK-1, Kinase insert domain receptor, KDR, Protein-tyrosine kinase receptor flk-1, CD309
- Gen-ID
- 3791
- UniProt
- P35968
-
Sie sind hier:
